Home › Trial NCT00003148
Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
- Trial IDNCT00003148
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC
- Enrollment86
- Start date1997-10
- ConditionsLeukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.